Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H18N2O3S |
Molecular Weight | 354.423 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(O)C(CSC2=CC=CC=C2)=CC(\C=C(/C#N)C(N)=O)=C1
InChI
InChIKey=YKLMGKWXBLSKPK-RIYZIHGNSA-N
InChI=1S/C19H18N2O3S/c1-2-24-17-10-13(8-14(11-20)19(21)23)9-15(18(17)22)12-25-16-6-4-3-5-7-16/h3-10,22H,2,12H2,1H3,(H2,21,23)/b14-8+
Molecular Formula | C19H18N2O3S |
Molecular Weight | 354.423 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8177967Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7834843 | https://www.ncbi.nlm.nih.gov/pubmed/18077363 | https://www.ncbi.nlm.nih.gov/pubmed/1479375 | https://www.ncbi.nlm.nih.gov/pubmed/15744060
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8177967
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7834843 | https://www.ncbi.nlm.nih.gov/pubmed/18077363 | https://www.ncbi.nlm.nih.gov/pubmed/1479375 | https://www.ncbi.nlm.nih.gov/pubmed/15744060
ST-638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenyl-methylcinnamamide) is a protein tyrosine kinase inhibitor that also inhibits HGF-induced MAP kinase activation in hepatocytes. ST638 has also shown to inhibit PC-PLD (phospholipase D) activity in human neutrophils and suppresses tyrosine phosphorylation induced by tumor necrosis factor-α and phorbol myristate acetate in neutrophils and by angiotensin II in cardiac fibroblasts.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL203 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1479375 |
400.0 nM [IC50] | ||
Target ID: CHEMBL3788 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18077363 |
|||
Target ID: CHEMBL2345 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18077363 |
|||
Target ID: CHEMBL2835 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18077363 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8177967
Rats were treated with ST-638 (30 or 100 mg/kg)
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15744060
Rats hepatocytes were isolated by in vitro collagenase perfusion and low speed centrifugation. Cell viability was determined by trypan blue exclusion and ranged from 85 to 95%. The hepatocytes were cultured for 24 h in monolayers in a plastic dish (1x10^5 cells/cm2) in Williams’ medium E containing 10% fetal calf serum, 10 nM insulin, 10 nM dexamethasone and 5 KIU/ml aprotinin under 5%CO2 atmosphere. After removal of the medium by aspiration, monolayers of hepatocytes in the dish were further incubated for 0—90 min in Williams’ medium E containing 2% bovine serum albumin with or without the addition of heparin in the presence of ST-638 (1-5mM). The hepatocytes were harvested and centrifuged at 50xg for 5 min to remove cellular debris. The obtained supernatant served as the preparation for the released HTGL activity. HTGL activity was determined by a method using glycerol tri[1-14C]oleate (1.2mkM; 2.5 kBq/ml) as a substrate
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:10:04 GMT 2023
by
admin
on
Fri Dec 15 19:10:04 GMT 2023
|
Record UNII |
6X89Y2007R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6X89Y2007R
Created by
admin on Fri Dec 15 19:10:04 GMT 2023 , Edited by admin on Fri Dec 15 19:10:04 GMT 2023
|
PRIMARY | |||
|
DTXSID701147014
Created by
admin on Fri Dec 15 19:10:04 GMT 2023 , Edited by admin on Fri Dec 15 19:10:04 GMT 2023
|
PRIMARY | |||
|
107761-24-0
Created by
admin on Fri Dec 15 19:10:04 GMT 2023 , Edited by admin on Fri Dec 15 19:10:04 GMT 2023
|
PRIMARY | |||
|
5941457
Created by
admin on Fri Dec 15 19:10:04 GMT 2023 , Edited by admin on Fri Dec 15 19:10:04 GMT 2023
|
PRIMARY |